Serum calcification propensity is a strong and independent determinant of cardiac and all-cause mortality in kidney transplant recipients

American Journal of Transplantation

Volumn 16, Issue 1, 2016, Pages 204-212

  Dahle, D O ^a,b   Asberg A ^a,c,d   Hartmann, A ^a,b   Holdaas, H ^a   Bachtler, M ^e   Jenssen, T G ^a,f   Dionisi, M ^g   Pasch, A ^e,h  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Rikshospitalet   (Norway)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF TROMSØ   (Norway)

^g CALCISCON AG   (Switzerland)

^h UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BASILIXIMAB; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PHOSPHATE; PREDNISOLONE; TACROLIMUS;

ADULT; ALBUMIN BLOOD LEVEL; ANTIBODY MEDIATED REJECTION; AORTA FLOW; AORTIC PULSE WAVE VELOCITY; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PULSE WAVE; SUDDEN CARDIAC DEATH; TIME; TRANSFORMATION TIME; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; AGED; BLOOD; BONE MINERALIZATION; CALCINOSIS; CARDIOVASCULAR DISEASES; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK FACTOR;

ADULT; AGED; CALCIFICATION, PHYSIOLOGIC; CALCINOSIS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PULSE WAVE ANALYSIS; RISK FACTORS; TRANSPLANT RECIPIENTS;

EID: 84956915430     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13443     Document Type: Article

References (38)

1. Jardine AG, Gaston RS, Fellstrom BC, Holdaas H., Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet 2011; 378: 1419-1427.
2. Foley RN, Parfrey PS, Sarnak MJ., Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119.
3. Pilmore H, Dent H, Chang S, McDonald SP, Chadban SJ., Reduction in cardiovascular death after kidney transplantation. Transplantation 2010; 89: 851-857.
4. Iribarren C, Sidney S, Sternfeld B, Browner WS., Calcification of the aortic arch: Risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000; 283: 2810-2815.
5. Kavousi M, Elias-Smale S, Rutten JH, et al., Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study. Ann Intern Med 2012; 156: 438-444.
6. Yeboah J, McClelland RL, Polonsky TS, et al., Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012; 308: 788-795.
7. Criqui MH, Denenberg JO, McClelland RL, et al., Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2014; 34: 1574-1579.
8. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM., Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942.
9. Nguyen PT, Henrard S, Coche E, Goffin E, Devuyst O, Jadoul M., Coronary artery calcification: A strong predictor of cardiovascular events in renal transplant recipients. Nephrol Dial Transplant 2010; 25: 3773-3778.
10. Hernandez D, Rufino M, Bartolomei S, et al., Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int 2005; 67: 2015-2020.
11. Allison MA, Wright CM., Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1). Int J Cardiol 2005; 98: 325-330.
12. Budoff MJ, Rader DJ, Reilly MP, et al., Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 2011; 58: 519-526.
13. Goodman WG, Goldin J, Kuizon BD, et al., Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
14. Nguyen PT, Coche E, Goffin E, et al., Prevalence and determinants of coronary and aortic calcifications assessed by chest CT in renal transplant recipients. Am J Nephrol 2007; 27: 329-335.
15. Chue CD, Townend JN, Steeds RP, Ferro CJ,. Arterial stiffness in chronic kidney disease: Causes and consequences. Heart 2010; 96: 817-823.
16. Verbeke F, Marechal C, Van Laecke S, et al., Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension 2011; 58: 833-838.
17. Dahle DO, Eide IA, Asberg A, et al., Aortic stiffness in a mortality risk calculator for kidney transplant recipients. Transplantation 2015. [Epub ahead of print].
18. Ben-Shlomo Y, Spears M, Boustred C, et al., Aortic pulse wave velocity improves cardiovascular event prediction: An individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63: 636-646.
19. Johnsson MS, Nancollas GH., The role of brushite and octacalcium phosphate in apatite formation. Crit Rev Oral Biol Med 1992; 3: 61-82.
20. Habraken WJ, Tao J, Brylka LJ, et al., Ion-association complexes unite classical and non-classical theories for the biomimetic nucleation of calcium phosphate. Nat Commun 2013; 4: 1507.
21. Pasch A, Farese S, Graber S, et al., Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 2012; 23: 1744-1752.
22. Smith ER, Ford ML, Tomlinson LA, et al., Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 2014; 25: 339-348.
23. Keyzer CA, de Borst MH, van den Berg E, et al., Calcification propensity and survival among renal transplant recipients. J Am Soc Nephrol 2015. [Epub ahead of print].
24. Racusen LC, Solez K, Colvin RB, et al., The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
25. Levey AS, Coresh J, Greene T, et al., Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
26. Van Bortel LM, Laurent S, Boutouyrie P, et al., Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30: 445-448.
27. Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellstrom B., A cardiovascular risk calculator for renal transplant recipients. Transplantation 2012; 94: 57-62.
28. Soveri I, Snyder J, Holdaas H, et al., The external validation of the cardiovascular risk equation for renal transplant recipients: Applications to BENEFIT and BENEFIT-EXT trials. Transplantation 2013; 95: 142-147.
29. Zoungas S, Kerr PG, Chadban S, et al., Arterial function after successful renal transplantation. Kidney Int 2004; 65: 1882-1889.
30. Strozecki P, Adamowicz A, Kozlowski M, Wlodarczyk Z, Manitius J., Progressive arterial stiffening in kidney transplant recipients. Ann Transplant 2011; 16: 30-35.
31. Benetos A, Adamopoulos C, Bureau J-M, et al., Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105: 1202-1207.
32. Briet M, Collin C, Karras A, et al., Arterial remodeling associates with CKD progression. J Am Soc Nephrol 2011; 22: 967-974.
33. Utescu MS, Couture V, Mac-Way F, et al., Determinants of progression of aortic stiffness in hemodialysis patients: A prospective longitudinal study. Hypertension 2013; 62: 154-160.
34. Guerin AP, London GM, Marchais SJ, Metivier F., Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021.
35. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM., Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
36. Jahnen-Dechent W, Heiss A, Schafer C, Ketteler M., Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011; 108: 1494-1509.
37. Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG., Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant 2012; 27: 1957-1966.
38. Smith ER, Hanssen E, McMahon LP, Holt SG,. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One 2013; 8: e60904.